Note: Ingredients listed on restricted chemical lists
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
General Information
Revision date
2021-04-22
Product name
PAZOPANIB 200 MG AND 400 MG TABLETS
Product Synonyms
PAZOPANIB HYDROCHLORIDE, FORMULATED PRODUCT
1.2.1 Relevant identified uses
Bulk Formulated Product
supplier name
GlaxoSmithKline Korea
Icons in SDS
Company Information
company name
GlaxoSmithKline Korea
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H360, H372, H411
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
A. Hazard category/Classification
Physical hazards
Not classified.
Health hazards
Carcinogenicity Category 2 Reproductive toxicity Category 1B Specific target organ toxicity following Category 1 repeated exposure
Environmental hazards
Hazardous to the aquatic environment, Category 2
Long term hazards
B. Warning label items including precautionary statement
Signal word
Danger
Hazard statements
H351 Suspected of causing cancer. H360 May damage fertility or the unborn child. H372 Causes damage to organs through prolonged or repeated exposure. H411 Toxic to aquatic life with long lasting effects.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P273 Avoid release to the environment. P280 Wear protective gloves/protective clothing/eye protection/face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/attention. P391 Collect spillage.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations. C. Other hazards not included Caution - Pharmaceutical agent. See section 11 for additional information on health hazards. in the hazard category criteria (e.g. dust explosion hazard)
Additional information
19.4 % of the mixture consists of component(s) of unknown acute oral toxicity. 99.3 % of the mixture consists of component(s) of unknown acute dermal toxicity. 30.7 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 25.8 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
